MEDIPART ApS: Financial statements 2024
CVR: 28895399
Source: annual report 2024, Danish Business Authority
01/08/2023 – 31/07/2024
MEDIPART ApS (CVR 28895399) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -325,864 and a net result of DKK 4,660 compared with DKK -1,522,856 the year before. Equity in the 2024 report amounted to DKK 11,514,727. The solvency ratio was 99.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -325,864
- Profit/Loss
- DKK 4,660
- Equity
- DKK 11,514,727
- Total Assets
- DKK 11,573,370
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -326 t. | 5 t. | 11.5 mio. | 1 |
| 2023 | - | -706 t. | -1.5 mio. | 11.5 mio. | 1 |
| 2022 | - | -155 t. | 862 t. | 13 mio. | 1 |
| 2021 | - | 7.6 mio. | 5.6 mio. | 12.2 mio. | 1 |
| 2020 | - | 8 t. | -373 t. | 6.5 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MEDIPART ApS
MEDIPART ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2005. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Rikke Nygaard. The company is owned by Erik Nygaard. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -64,509 and a net result of DKK 138,106 compared with DKK 4,660 the year before. Equity in the 2025 report amounted to DKK 11,652,834.